Skip to main content
. 2015 Mar 6;15:221. doi: 10.1186/s12889-015-1573-0

Table 4.

Overall Generalized Impact Fraction* of reduction in unfavorable levels of cardiovascular health metrics by sex

Scenario 1‡ Scenario 2§ Scenario 3||
Cardiovascular health metrics† GIF (95% SI) Prev, no** GIF (95% SI) Prev, no** GIF (95% SI) Prev, no**
Men
Body mass index 6.2 (4.0, 8.3) 48 10.4 (6.7, 13.8) 80 20.7 (13.5, 27.7) 159
Cholesterol 9.9 (6.6, 13.1) 76 16.4 (11.0, 21.8) 126 32.9 (22.0, 43.6) 252
Blood pressure 10.4 (4.6, 15.3) 80 17.3 (7.7, 25.5) 133 34.6 (15.5, 51.1) 265
Smoking 5.5 (4.3, 6.8) 43 9.3 (7.2, 11.4) 71 18.5 (14.3, 22.8) 142
Physical activity 3.9 (2.0, 5.7) 30 6.6 (3.4, 9.5) 50 13.1 (6.8, 18.9) 100
Diabetes 2.2 (1.3, 3.1) 15 3.6 (2.2, 5.2) 26 7.2 (4.4, 10.3) 51
Women
Body mass index 3.2 (0.4, 6.1) 12 5.4 (0.6, 10.1) 20 10.8 (1.2, 20.2) 40
Cholesterol 6.7 (−1.1, 13.7) 25 11.2 (−1.8, 22.8) 42 22.3 (−3.5, 45.5) 84
Blood pressure 15.1 (8.1, 20.7) 57 25.2 (13.5, 34.5) 95 50.4 (27.0, 69.0) 189
Smoking 7.1 (5.6, 8.7) 27 11.9 (9.3, 14.5) 44 23.8 (18.6, 29.1) 88
Physical activity 5.4 (2.4, 8.1) 20 9.0 (4.0, 13.5) 34 17.8 (8.1, 26.9) 67
Diabetes 2.8 (1.7, 4.0) 10 4.7 (2.8, 6.6) 17 9.3 (5.7, 13.2) 35

GIF, Generalized Impact Fraction in percent; SI, 2.5 % to 97.5% Simulation Interval from 10,000 bootstrapped data sets.

*The overall GIF using the case-load weighted sum method.

†Ideal levels of the health metrics.

Body Mass Index < 25 kg/m2.

Total cholesterol < 5.18 mmol/l (<200 mg/dl).

Systolic blood pressure < 120 mmHg and diastolic blood pressure < 80 mmHg.

Non-smokers.

Moderate physical activity ≥ 3 hours per week or vigorous physical activity ≥ 1 hours per week.

Non – Diabetes.

‡30% decrease in subjects not in ideal levels, with movement of this 30% to ideal levels.

§50% decrease in subjects not in ideal levels, with movement of this 50% to ideal levels.

||100% elimination of subjects not in ideal levels, with movement of this 100% to ideal levels.

**The preventable number of MI per 100,000 person-years.

The Tromsø Study 1994–2008.